• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恩度联合人参皂甙 Rg3 对荷瘤小鼠乳腺癌肿瘤生长的抑制作用。

Inhibiting effect of Endostar combined with ginsenoside Rg3 on breast cancer tumor growth in tumor-bearing mice.

机构信息

Oncology Department No. 2, Linyi People's Hospital, Linyi City, Shandong Province, 276000, China.

Radiotherapy Department, Linyi People's Hospital, Linyi City, Shandong Province, 276000, China.

出版信息

Asian Pac J Trop Med. 2016 Feb;9(2):180-3. doi: 10.1016/j.apjtm.2016.01.010. Epub 2016 Jan 11.

DOI:10.1016/j.apjtm.2016.01.010
PMID:26919952
Abstract

OBJECTIVE

To study the inhibiting effect of Endostar combined with ginsenoside Rg3 on breast cancer tumor growth in tumor-bearing mice.

METHODS

Female mice were selected as experimental animals, and breast cancer tumor-bearing mouse models were established and then divided into groups A, B, C and D that respectively received saline, recombinant human endostatin, ginsenosides Rg3 and recombinant human endostatin combined with Rg3 intervention; 7 d, 14 d and 21 d after intervention, tumor tissue volume was measured; 21 d after intervention, mice were killed, tumor tissue was collected, and mRNA contents of angiogenesis molecules, invasion molecules, autophagy marker molecules and autophagy signaling pathway molecules were detected.

RESULTS

At 7 d, 14 d and 21 d after intervention, tumor tissue volume of groups B, C and D was lower than that of group A, and tumor tissue volume of group D was lower than that of groups B and C; mRNA contents of VEGFA, VEGFB, VEGFC, MMP2, MMP9, p62, mTOR, PI3K, Akt, JNK and Beclin-1 in tumor tissue of groups B, C and D were significantly lower than those of group A, and LC3-II/LC3-I was significantly higher than that of group A; mRNA contents of VEGFA, VEGFB, VEGFC, MMP2, MMP9, p62, mTOR, PI3K, Akt, JNK and Beclin-1 in tumor tissue of group D were significantly lower than those of groups B and C, and LC3-II/LC3-I was higher than that of groups B and C.

CONCLUSIONS

Endostar combined with ginsenoside Rg3 has stronger inhibiting effect on breast cancer tumor growth in tumor-bearing mice than single drug, and it can inhibit angiogenesis and cell invasion, and enhance cell autophagy.

摘要

目的

研究恩度联合人参皂甙 Rg3 对荷瘤小鼠乳腺癌肿瘤生长的抑制作用。

方法

选用雌性小鼠作为实验动物,建立乳腺癌荷瘤小鼠模型,然后分为 A、B、C、D 组,分别给予生理盐水、重组人血管内皮抑制素、人参皂甙 Rg3、重组人血管内皮抑制素联合 Rg3 干预;干预后 7、14、21 d 测量肿瘤组织体积;干预 21 d 后处死小鼠,收集肿瘤组织,检测血管生成分子、侵袭分子、自噬标记分子和自噬信号通路分子的 mRNA 含量。

结果

干预后 7、14、21 d,B、C、D 组肿瘤组织体积均低于 A 组,D 组低于 B、C 组;B、C、D 组肿瘤组织中 VEGFA、VEGFB、VEGFC、MMP2、MMP9、p62、mTOR、PI3K、Akt、JNK 和 Beclin-1 的 mRNA 含量均明显低于 A 组,LC3-II/LC3-I 明显高于 A 组;D 组肿瘤组织中 VEGFA、VEGFB、VEGFC、MMP2、MMP9、p62、mTOR、PI3K、Akt、JNK 和 Beclin-1 的 mRNA 含量均明显低于 B、C 组,LC3-II/LC3-I 高于 B、C 组。

结论

恩度联合人参皂甙 Rg3 对荷瘤小鼠乳腺癌肿瘤生长的抑制作用强于单药,能抑制血管生成和细胞侵袭,增强细胞自噬。

相似文献

1
Inhibiting effect of Endostar combined with ginsenoside Rg3 on breast cancer tumor growth in tumor-bearing mice.恩度联合人参皂甙 Rg3 对荷瘤小鼠乳腺癌肿瘤生长的抑制作用。
Asian Pac J Trop Med. 2016 Feb;9(2):180-3. doi: 10.1016/j.apjtm.2016.01.010. Epub 2016 Jan 11.
2
Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway.人参皂苷Rg3通过VEGFR - 2介导的PI3K/Akt/mTOR信号通路抑制子宫内膜异位症大鼠模型中的血管生成。
PLoS One. 2017 Nov 15;12(11):e0186520. doi: 10.1371/journal.pone.0186520. eCollection 2017.
3
Ginsenoside 20(S)-Rg3 induced autophagy to inhibit migration and invasion of ovarian cancer.人参皂苷 20(S)-Rg3 通过诱导自噬抑制卵巢癌细胞的迁移和侵袭。
Biomed Pharmacother. 2017 Jan;85:620-626. doi: 10.1016/j.biopha.2016.11.072. Epub 2016 Nov 26.
4
[Inhibitory Effect of Ginsenoside Rg3 Combined With 5-Fluorouracil on Tumor Angiogenesis and Tumor Growth of Colon Cancer in Mice: An Experimental Study].人参皂苷Rg3联合5-氟尿嘧啶对小鼠结肠癌肿瘤血管生成及肿瘤生长的抑制作用:一项实验研究
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Jan 20;55(1):111-117. doi: 10.12182/20240160506.
5
Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer.人参皂苷Rg3联合环磷酰胺对卵巢癌生长和血管生成的抑制作用
Chin Med J (Engl). 2007 Apr 5;120(7):584-8.
6
[Effect of ginsenoside Rg3 on the progression of orthotopically xenotransplanted human breast cancer in nude mice and its mechanism].人参皂苷Rg3对裸鼠原位移植人乳腺癌进展的影响及其机制
Sichuan Da Xue Xue Bao Yi Xue Ban. 2003 Jul;34(3):546-8.
7
[Experimental study on anti-angiogenesis in mice with Lewis lung carcinoma by low-dose of cyclophosphamide combined with ginsenoside Rg3].低剂量环磷酰胺联合人参皂苷Rg3对Lewis肺癌小鼠抗血管生成的实验研究
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Aug;25(8):730-3.
8
Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell.抑制PI3K-Akt信号通路参与人参皂苷Rg3对肺癌细胞的抗肿瘤作用。
Biomed Pharmacother. 2017 Jan;85:16-21. doi: 10.1016/j.biopha.2016.11.096. Epub 2016 Dec 5.
9
Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis.人参皂苷Rg3对卵巢癌转移的抑制作用。
Chin Med J (Engl). 2008 Aug 5;121(15):1394-7.
10
[Antiangiogenesis of ginsenoside Rg3 in severe combined immunodeficient mice with human ovarian carcinoma].人参皂苷Rg3对人卵巢癌严重联合免疫缺陷小鼠的抗血管生成作用
Zhonghua Fu Chan Ke Za Zhi. 2002 Apr;37(4):227-30.

引用本文的文献

1
Ginsenoside Rg3 decreases breast cancer stem-like phenotypes through impairing MYC mRNA stability.人参皂苷Rg3通过损害MYC mRNA稳定性来降低乳腺癌干细胞样表型。
Am J Cancer Res. 2024 Feb 15;14(2):601-615. doi: 10.62347/GYXE7741. eCollection 2024.
2
Mechanism Research and Application for Ginsenosides in the Treatment of Hepatocellular Carcinoma.人参皂苷治疗肝细胞癌的作用机制研究及应用。
Biomed Res Int. 2023 Nov 16;2023:7214037. doi: 10.1155/2023/7214037. eCollection 2023.
3
Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer.
人参皂苷:改变癌细胞的基本特征以达到治疗乳腺癌的目的。
Chin Med. 2023 Sep 25;18(1):125. doi: 10.1186/s13020-023-00822-9.
4
Polymer-Based Wound Dressings Loaded with Ginsenoside Rg3.载有人参皂苷 Rg3 的基于聚合物的伤口敷料。
Molecules. 2023 Jun 28;28(13):5066. doi: 10.3390/molecules28135066.
5
Exploring the anti-cancer potential of dietary phytochemicals for the patients with breast cancer: A comprehensive review.探讨膳食植物化学物对乳腺癌患者的抗癌潜力:全面综述。
Cancer Med. 2023 Jul;12(13):14556-14583. doi: 10.1002/cam4.5984. Epub 2023 May 3.
6
Anti-cancer effect and potential microRNAs targets of ginsenosides against breast cancer.人参皂苷对乳腺癌的抗癌作用及潜在的微小RNA靶点
Front Pharmacol. 2022 Oct 5;13:1033017. doi: 10.3389/fphar.2022.1033017. eCollection 2022.
7
Ginsenoside Rg5 Sensitizes Paclitaxel-Resistant Human Cervical-Adeno-Carcinoma Cells to Paclitaxel-And Enhances the Anticancer Effect of Paclitaxel.人参皂苷 Rg5 增敏紫杉醇耐药的人宫颈腺癌细胞对紫杉醇的敏感性并增强紫杉醇的抗癌作用。
Genes (Basel). 2022 Jun 24;13(7):1142. doi: 10.3390/genes13071142.
8
Mechanistic evaluation of phytochemicals in breast cancer remedy: current understanding and future perspectives.乳腺癌治疗中植物化学物质的机制评估:当前认识与未来展望
RSC Adv. 2018 Aug 22;8(52):29714-29744. doi: 10.1039/c8ra04879g. eCollection 2018 Aug 20.
9
HYD-PEP06 suppresses hepatocellular carcinoma metastasis, epithelial-mesenchymal transition and cancer stem cell-like properties by inhibiting PI3K/AKT and WNT/-catenin signaling activation.HYD-PEP06通过抑制PI3K/AKT和WNT/β-连环蛋白信号激活来抑制肝细胞癌转移、上皮-间质转化及癌症干细胞样特性。
Acta Pharm Sin B. 2021 Jun;11(6):1592-1606. doi: 10.1016/j.apsb.2021.03.040. Epub 2021 Apr 2.
10
Therapeutic potential of ginsenoside Rg3 and Rf for Huntington's disease.人参皂苷 Rg3 和 Rf 治疗亨廷顿病的潜力。
In Vitro Cell Dev Biol Anim. 2021 Jun;57(6):641-648. doi: 10.1007/s11626-021-00595-1. Epub 2021 Jun 14.